Quanterix Announces Collaboration With Oncogenesis to Develop Cervical Screening Test
OCTOBER 22, 2018 Quanterix’ technology to be used in multiplex diagnostic test for cervical disease detection Lexington, Mass. – October 22, 2018 — Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced a collaboration agreement with OncoGenesis, a molecular protein-based cervical screening company, to develop a quantitative, protein... Read more